<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13496">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931227</url>
  </required_header>
  <id_info>
    <org_study_id>TempCore</org_study_id>
    <nct_id>NCT02931227</nct_id>
  </id_info>
  <brief_title>Accuracy of Zero Heat Flux Cutaneous Temperature in Intensive Care Adults</brief_title>
  <acronym>TempCore</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      Fifty two ICU patients over a 4-months period who required continuous temperature monitoring
      were included in the study, after informed consent.

      Interventions : All patients had esophageal temperature probe and a non invasive cutaneaous
      device, to monitor their core temperature continuously.

      Comparison to the esophageal temperature, considered as the reference in this study, used
      the Bland and Altman method with adjustment for multiple measurements per patient.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Comparison a continuous non-invasive cutaneous temperature using zero-heat flux method</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Patient Surgical or Neurosurgical Resuscitation</condition>
  <arm_group>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperthermia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>temperature obtained by the non-invasive method of zero-heat flux</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>esophageal temperature</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intracerebral temperature</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  minimum 18 years old

          -  patients who required core temperature monitoring

        Exclusion Criteria:

          -  front disrepair

          -  refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Claire DAYHOT-FIZELIER, PU-PH</last_name>
    <phone>0549441369</phone>
    <phone_ext>+33</phone_ext>
    <email>claire.dahyot-fizelier@chu-poitiers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire DAYHOT-FIZELIER, PU-PH</last_name>
      <phone>0549441369</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.dahyot-fizelier@chu-poitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>October 10, 2016</lastchanged_date>
  <firstreceived_date>September 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
